Edition:
United Kingdom

ACADIA Pharmaceuticals Inc (ACAD.OQ)

ACAD.OQ on NASDAQ Stock Exchange Global Select Market

27.86USD
17 Nov 2017
Change (% chg)

-- (--)
Prev Close
$27.86
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
459,830
52-wk High
$41.20
52-wk Low
$24.32

Latest Key Developments (Source: Significant Developments)

Acadia Pharmaceuticals posts Q3 loss of $0.53 per share
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Acadia Pharmaceuticals Inc :Acadia Pharmaceuticals reports third quarter 2017 financial results.Q3 loss per share $0.53.Q3 sales $35.6 million versus I/B/E/S view $32 million.Sees FY 2017 sales $124 million to $127 million.Q3 earnings per share view $-0.62 -- Thomson Reuters I/B/E/S.  Full Article

Acadia Pharmaceuticals announces proposed public offering of common stock
Monday, 8 Aug 2016 

Acadia Pharmaceuticals Inc : Acadia Pharmaceuticals announces proposed public offering of common stock .Acadia Pharmaceuticals Inc says that it intends to offer and sell, subject to market and other conditions, $200 million of its common stock.  Full Article

Acadia Pharmaceuticals reports Q2 2016 financial results
Thursday, 4 Aug 2016 

Acadia Pharmaceuticals Inc : Acadia Pharmaceuticals reports second quarter 2016 financial results .Qtrly loss per share $0.63.  Full Article

UK's CMA could accept undertakings on Acadia's Priory Group deal
Thursday, 28 Jul 2016 

UK's CMA : To look at Acadia's undertakings offer in relation to acquisition of Priory Group No 1 Ltd in detail . Considers that undertaking offered, or a modified version of it, might be accepted .Now has until 23 September to decide whether to accept undertaking, with possibility to extend this timeframe to 18 november.  Full Article

ACADIA Pharmaceuticals Announces Proposed Public Offering of Common Stock
Tuesday, 5 Jan 2016 

ACADIA Pharmaceuticals Inc:t intends to offer and sell, subject to market and other conditions, $300,000,000 of shares of its common stock in an underwritten public offering.There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.BofA Merrill Lynch and J.P. Morgan Securities LLC are acting as the joint book-running managers for the offering.ACADIA intends to grant the underwriters a 30-day option to purchase an additional $45,000,000 of shares of its common stock.  Full Article